As a result of semaglutide GLP-1s action, your appetite is reduced
Previous research has shown that, among gut bacteria, the abundance of Lachnospira and Clostridium were significantly high in IBS patients (Zhuang et al., 2018), and Clostridium difficile has been shown to increase the risk of post-infectious IBS (Piche et al., 2007
Patients should stay well-hydrated, especially if experiencing vomiting or diarrhoea, as dehydration can lead to acute kidney injury
Your journey is unique, and our ongoing support reflects that commitment to your personalized care
Patients taking semaglutide should be educated about the warning signs of gallbladder disease to enable early detection and appropriate management
As an FDA-approved dual GLP-1/GIP receptor agonist, tirzepatide is reshaping the approach to weight management by significantly increasing the potential for sustained weight loss